EUROAPI’s Climate Commitment Strengthened by SBTi Validation
EUROAPI's Commitment to Sustainable Practices
In a significant step toward environmental sustainability, EUROAPI has been recognized by the Science Based Targets initiative (SBTi) for its ambitious climate targets. This validation emphasizes EUROAPI's dedication to adhering to the goals set forth in the Paris Agreement, particularly the commitment to limit global warming to 1.5°C above pre-industrial levels.
Setting Specific Emission Reduction Goals
Goals for Greenhouse Gas Emissions
EUROAPI is set to achieve a remarkable 42% reduction in Scope 1 and 2 greenhouse gas (GHG) emissions by the year 2030, using 2022 as the base year for comparison. In parallel, the company is also targeting a 25% decrease in Scope 3 GHG emissions in the same timeframe, reinforcing its comprehensive approach to carbon footprint reduction.
Statements from Leadership
David Seignolle, the Chief Executive Officer of EUROAPI, expressed pride in the company's validation from the SBTi, stating, “This validation is a strong recognition of our commitment to conducting our industrial operations as sustainably as possible. Improving our environmental footprint is one of our ESG priorities, whether it’s climate change mitigation, circular economy actions, or protecting biodiversity.”
Echoing this sentiment, Sylvia Cabrillac-Rives, Chief Strategy Officer, highlighted the tangible progress already made, emphasizing that the company has made strides not only by cutting waste but also by increasing its renewable energy usage.
Measurable Improvements in Environmental Performance
Recent Achievements
Between 2022 and 2024, EUROAPI has made remarkable strides in enhancing its environmental footprint. Noteworthy achievements include a 28% reduction in waste produced, a 14% decrease in solvent usage, and a 12% drop in energy consumption. This collective effort has led to the elimination of nearly 180,000 tons of CO2 equivalent emissions, a figure comparable to the annual emissions of a city with a population of around 20,000.
Furthermore, EUROAPI has now quantified the carbon footprint for over 70 active pharmaceutical ingredients (APIs), demonstrating transparency and accountability in its operations. An impressive 100% of the electricity harnessed by the company is sourced from renewable energy options, marking a significant milestone in their sustainability journey.
About EUROAPI
EUROAPI is dedicated to reinventing active ingredient solutions, striving to meet both customer and patient needs across global markets. As a key player in the active pharmaceutical ingredients sector, EUROAPI boasts a diverse portfolio of approximately 200 products, with ongoing innovations being developed through its Contract Development and Manufacturing Organization (CDMO) activities.
The driving force behind EUROAPI's mission is its dedicated team of 3,270 employees, inspired to enhance health outcomes by improving access to essential therapies. With solid research and development capabilities supported by five manufacturing sites across Europe, EUROAPI is committed to producing the highest quality APIs for customers situated in over 80 countries. EUROAPI is listed on Euronext Paris under the ticker symbol PARIS:EAPI, indicating its strong market presence.
Frequently Asked Questions
What is the significance of EUROAPI's validation by SBTi?
The validation signifies that EUROAPI's planned emissions reductions align with scientific benchmarks aimed at limiting global warming, showcasing its commitment to sustainable business practices.
What specific emissions targets has EUROAPI set?
EUROAPI aims for a 42% reduction in Scope 1 and 2 greenhouse gas emissions and a 25% reduction in Scope 3 emissions by 2030, based on 2022 levels.
How has EUROAPI progressed in its sustainability efforts?
EUROAPI has achieved substantial reductions in waste, solvent use, and energy consumption, demonstrating its commitment to enhancing its environmental performance.
How does EUROAPI ensure the sustainability of its product offerings?
By measuring the carbon footprint of its active pharmaceutical ingredients and utilizing 100% renewable energy, EUROAPI ensures that its operations are eco-friendly and sustainable.
Where can I find more information about EUROAPI?
Additional information can be found on EUROAPI's official website, where details about their products, sustainability initiatives, and corporate values are shared.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.